8-K: AMMO Inc. Settles Long-Standing Litigation with Triton Value Partners, Gunbroker.com
Settlement Agreement Announcement
AMMO Inc. has reached a settlement agreement to resolve a legal dispute with Triton Value Partners and Gunbroker.com, involving a payment of $8 million and the potential cancellation of 2,857,143 shares of AMMO stock.
Summary
- AMMO Inc. has entered into a settlement agreement to resolve a lawsuit with Triton Value Partners, Donald Gasgarth, Paul Freischlag, Jr., Jeff Zwitter, Steven Urvan, TVP Investments LLC, and Gunbroker.com, LLC, IA TECH, LLC, and GB Investments, Inc.
- The settlement requires the Gunbroker Defendants to pay $8 million to the Plaintiffs.
- AMMO will deposit the $8 million into an escrow account within 45 days of the agreement's execution.
- Upon receipt of the funds, the Plaintiffs will dismiss the lawsuit, and the Urvan Defendants will dismiss their counterclaims.
- A portion of Steven Urvan's pledged AMMO shares, specifically a stock certificate for 2,857,143 shares, will be cancelled unless Urvan elects to make the settlement payment directly.
- If Urvan makes the payment directly, AMMO will release the stock certificate to him, subject to certain conditions.
- The agreement includes mutual releases of claims, except for claims between AMMO and Urvan related to a separate ongoing litigation.
Sentiment
Score: 6
Explanation: The settlement is a positive step in resolving a legal issue, but the financial cost and ongoing litigation with Urvan temper the overall sentiment. The potential stock dilution is also a concern.
Positives
- The settlement resolves a long-standing legal dispute, removing uncertainty and potential costs associated with ongoing litigation.
- The agreement provides a clear path for resolving the matter with a defined payment and potential stock cancellation.
- The mutual release of claims, except for the ongoing litigation between AMMO and Urvan, reduces the risk of future disputes related to this matter.
Negatives
- AMMO is required to tender $8 million to an escrow agent, which represents a cash outflow.
- The potential cancellation of 2,857,143 shares of AMMO stock could dilute existing shareholders if the shares are not cancelled and are released to Urvan.
- The ongoing litigation between AMMO and Urvan remains unresolved, indicating continued legal risk and potential costs.
Risks
- The ongoing litigation between AMMO and Urvan could result in further financial liabilities and legal expenses.
- If Urvan elects to make the settlement payment directly, the potential release of 2,857,143 shares to Urvan could negatively impact the stock price.
- There is a risk that the settlement terms may not be fully executed as agreed, potentially leading to further disputes.
Future Outlook
The settlement is expected to resolve the current litigation, but the ongoing dispute between AMMO and Urvan remains a potential future issue. The company will need to manage the escrow process and potential stock cancellation or release.
Management Comments
- The document does not contain any direct quotes from management, but the signing of the agreement by CEO Jared R. Smith indicates management's approval and commitment to the settlement.
Industry Context
The settlement of this legal dispute is specific to AMMO Inc. and its past acquisitions and does not directly reflect broader industry trends. However, it highlights the importance of due diligence and risk management in mergers and acquisitions.
Comparison to Industry Standards
- It is difficult to compare this settlement to industry standards as it is specific to the circumstances of AMMO's past merger with Gemini Direct Investments and the subsequent litigation.
- The settlement amount of $8 million is a significant sum for a company of AMMO's size, but the impact will depend on the company's overall financial health and the outcome of the ongoing litigation with Urvan.
- The potential cancellation of 2,857,143 shares is a unique aspect of this settlement and does not have a direct industry comparison.
Legal Proceedings
- The document details the settlement of the litigation between Triton Value Partners, et al. and TVP Investments, LLC, et al.
- The document also references ongoing litigation between Urvan and AMMO in Delaware.
Stakeholder Impact
- Shareholders may experience a slight negative impact due to the cash outflow of $8 million and the potential dilution from the release of 2,857,143 shares to Urvan.
- Employees may experience a positive impact as the settlement reduces uncertainty and potential disruption from the litigation.
- Customers and suppliers are unlikely to be directly impacted by this settlement.
Next Steps
- AMMO will need to deposit $8 million into escrow within 45 days.
- The escrow agent will release the funds to the Plaintiffs and the stock certificate to the transfer agent for cancellation or to Urvan, depending on his election.
- The Plaintiffs will dismiss the lawsuit, and the Urvan Defendants will dismiss their counterclaims.
- AMMO will continue to manage the ongoing litigation with Urvan.
Key Dates
| Date | Description |
|---|---|
| 2017-12-13 | Plaintiffs filed the initial action (the Triton Matter). |
| 2021-04-30 | AMMO, Speedlight Group I, LLC, Gemini Direct Investments, LLC, and Steven Urvan entered into a Merger Agreement and Pledge and Escrow Agreement. |
| 2024-01-11 | Urvan made a demand for indemnification on AMMO. |
| 2024-06-24 | Effective date of the Confidential Settlement Agreement and Mutual General Release. |
| 2024-06-28 | Date of the 8-K filing. |
Keywords
settlement, litigation, AMMO Inc, Triton Value Partners, Gunbroker.com, escrow, stock cancellation, mutual release, Steven Urvan, Merger Agreement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.